GlassScriptPhysician profile
Tara Elia
NPI 1497375166
$738.07
in general payments reported to CMS, 2019-2025
7 companies · $15.52 in 2025
The $15.52 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $74.09 · 2024: $648 · 2025: $15.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $352.78 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $149.65 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $124.86 | 2024 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $54.59 | 2024 | Cologuard Collection Kit |
| Grifols USA, LLC | $24.64 | 2024 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $16.03 | 2024 | Xarelto |
| Harmony Biosciences LLC | $15.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Elia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.